Literature DB >> 15969653

Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation.

Jagdeep K Sandhu1, Caroline Sodja, Kevan McRae, Yan Li, Peter Rippstein, Yau-Huei Wei, Boleslaw Lach, Fay Lee, Septimiu Bucurescu, Mary-Ellen Harper, Marianna Sikorska.   

Abstract

Reactive nitrogen and oxygen species (O2*-, H2O2, NO* and ONOO-) have been strongly implicated in the pathophysiology of neurodegenerative and mitochondrial diseases. In the present study, we examined the effects of nitrosative and/or nitrative stress generated by DETA-NO {(Z)-1-[2-aminoethyl-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate}, SIN-1 (3-morpholinosydnonimine hydrochloride) and SNP (sodium nitroprusside) on U87MG glioblastoma cybrids carrying wt (wild-type) and mutant [A3243G (Ala3243-->Gly)] mtDNA (mitochondrial genome) from a patient suffering from MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). The mutant cybrids had reduced activity of cytochrome c oxidase, significantly lower ATP level and decreased mitochondrial membrane potential. However, endogenous levels of reactive oxygen species were very similar in all cybrids regardless of whether they carried the mtDNA defects or not. Furthermore, the cybrids were insensitive to the nitrosative and/or nitrative stress produced by either DETA-NO or SIN-1 alone. Cytotoxicity, however, was observed in response to SNP treatment and a combination of SIN-1 and glucose-deprivation. The mutant cybrids were significantly more sensitive to these insults compared with the wt controls. Ultrastructural examination of dying cells revealed several characteristic features of autophagic cell death. We concluded that nitrosative and/or nitrative stress alone were insufficient to trigger cytotoxicity in these cells, but cell death was observed with a combination of metabolic and nitrative stress. The vulnerability of the cybrids to these types of injury correlated with the cellular energy status, which were compromised by the MELAS mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969653      PMCID: PMC1276916          DOI: 10.1042/BJ20050272

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Cultivation in glucose-deprived medium stimulates mitochondrial biogenesis and oxidative metabolism in HepG2 hepatoma cells.

Authors:  Katharina Weber; David Ridderskamp; Mark Alfert; Siegfried Hoyer; Rudolf J Wiesner
Journal:  Biol Chem       Date:  2002-02       Impact factor: 3.915

2.  Mitochondrial nitric oxide synthase.

Authors:  Paul S Brookes
Journal:  Mitochondrion       Date:  2004-03       Impact factor: 4.160

3.  Nitric oxide inhibits capacitative Ca2+ entry by suppression of mitochondrial Ca2+ handling.

Authors:  Baskaran Thyagarajan; Roland Malli; Kurt Schmidt; Wolfgang F Graier; Klaus Groschner
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 4.  Reactive oxygen species and mitochondrial diseases.

Authors:  I G Kirkinezos; C T Moraes
Journal:  Semin Cell Dev Biol       Date:  2001-12       Impact factor: 7.727

Review 5.  Mitochondrial nitric oxide synthase, oxidative stress and apoptosis.

Authors:  P Ghafourifar; U Bringold; S D Klein; C Richter
Journal:  Biol Signals Recept       Date:  2001 Jan-Apr

6.  Apoptosis in cultured hNT neurons.

Authors:  T Zigova; A E Willing; S Saporta; M M Daadi; M P McGrogan; T S Randall; T B Freeman; J Sanchez-Ramos; P R Sanberg
Journal:  Brain Res Dev Brain Res       Date:  2001-03-29

7.  Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required.

Authors:  J N Bates; M T Baker; R Guerra; D G Harrison
Journal:  Biochem Pharmacol       Date:  1991-12-11       Impact factor: 5.858

8.  Paradoxical fate and biological action of peroxynitrite on human platelets.

Authors:  M A Moro; V M Darley-Usmar; D A Goodwin; N G Read; R Zamora-Pino; M Feelisch; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 9.  Mitochondrial disease: mutations and mechanisms.

Authors:  Matthew McKenzie; Danae Liolitsa; Michael G Hanna
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 10.  Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?

Authors:  Céline Candé; Francesco Cecconi; Philippe Dessen; Guido Kroemer
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

View more
  5 in total

Review 1.  NO control of mitochondrial function in normal and transformed cells.

Authors:  Celia H Tengan; Carlos T Moraes
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-02-16       Impact factor: 3.991

Review 2.  Oxidative stress in inherited mitochondrial diseases.

Authors:  Genki Hayashi; Gino Cortopassi
Journal:  Free Radic Biol Med       Date:  2015-06-12       Impact factor: 7.376

3.  Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function.

Authors:  P B M de Andrade; B Rubi; F Frigerio; J M W van den Ouweland; J A Maassen; P Maechler
Journal:  Diabetologia       Date:  2006-05-31       Impact factor: 10.122

4.  KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts.

Authors:  Kang-Sik Seo; Jin-Hwan Kim; Ki-Nam Min; Jeong-A Moon; Tae-Chul Roh; Mi-Jung Lee; Kang-Woo Lee; Ji-Eun Min; Young-Mock Lee
Journal:  Front Neurol       Date:  2018-07-05       Impact factor: 4.003

5.  Degree of glutathione deficiency and redox imbalance depend on subtype of mitochondrial disease and clinical status.

Authors:  Gregory M Enns; Tereza Moore; Anthony Le; Kondala Atkuri; Monisha K Shah; Kristina Cusmano-Ozog; Anna-Kaisa Niemi; Tina M Cowan
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.